Objective: A recent meta-analysis has indicated that, in patients with dementia, the use of
atypical antipsychotics is associated with an excess mortality. Later observational studies …

Background Atypical antipsychotic agents are increasingly being used for the treatment of
behavioural and psychological symptoms of dementia. However, recent data suggest that …

Objective The authors sought to determine the effects of conventional and atypical
antipsychotic use on time to nursing home admission and time to death in a group of …

Background Antipsychotics are widely used to manage behavioral disorders in patients with
dementia. Recently, serious concerns have been raised about the stroke and mortality risk of …

Purpose To estimate the association between use of typical and atypical antipsychotics and
all‐cause mortality in a population of demented outpatients. Methods The study cohort …

Objective: Mortality rates in the year following new antipsychotic medication starts for
neuropsychiatric symptoms of dementia were compared with rates after starts of other …

Objective To investigate short-and long-term mortality risk associated with the use of
antipsychotics in dementia outpatients, assessing the risk over specific time frames and …

Background: Use of atypical antipsychotics for “off-label” indications, such as behavioral and
psychological symptoms of dementia, depression, and bipolar disorder, have been …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However …

Background: Antipsychotic drugs are widely used to manage behavioral and psychological
symptoms in dementia despite concerns about their safety. Objective: To examine the …